Coffee, cardiovascular and behavioral effects current research trends.
This review attempts to summarize cardiovascular and behavioral research on coffee over the last five years. Interest in these areas has increased relative to earlier periods, and new aspects have been considered. Acute cardiovascular effects induced by giving average total daily doses as a single dose to non-users or abstaining users have been compared between normotensives and hypertensives, between habitual users and non-users, and with and without additional mental stress. Implications for daily use were studied semichronically. Great interest has also been devoted to the putative atherogenic effects and to epidemiological associations with cardiovascular disease. Behavioral research has continued, in part, the tradition of assessing effects on performance and mood in random samples, in users and non-users, and in different personality types. Objective measures of sleepiness were increasingly used to assess the maintenance of wakefulness and the antagonism of physiologically or pharmacologically induced sleepiness. A recent topic involves the search for reasons underlying and maintaining the coffee drinking habit.
Bättig
K
K
Behavioral Biology Lab, ETH-Zentrum, Zürich, Switzerland.
D001519:Behavior / Q000187:drug effects*; D002110:Caffeine / Q000008:administration & dosage / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D004347:Drug Interactions; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D011597:Psychomotor Performance / Q000187:drug effects; D013315:Stress, Psychological / Q000378:metabolism
D002110:Caffeine